KBC Group
ELAN icon

KBC Group’s Elanco Animal Health ELAN Stock Holding History

KBC Group’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.2M Buy
91,785
+1,639
+2% +$40.1K 0.01% 642
2025
Q4 		$2.04M Hold
90,146
– – ﹤0.01% 601
2025
Q3 		$1.82M Hold
90,146
– – ﹤0.01% 608
2025
Q2 		$1.29M Sell
90,146
-8,528
-9% -$99.7K ﹤0.01% 640
2025
Q1 		$1.04M Sell
98,674
-224,828
-69% -$2.54M ﹤0.01% 664
2024
Q4 		$3.92M Buy
323,502
+234,840
+265% +$3.07M 0.01% 537
2024
Q3 		$1.3M Buy
88,662
+63
+0.1% +$878 ﹤0.01% 659
2024
Q2 		$1.28M Buy
88,599
+1,577
+2% +$25.2K ﹤0.01% 639
2024
Q1 		$1.42M Sell
87,022
-43,930
-34% -$687K ﹤0.01% 630
2023
Q4 		$1.95M Sell
130,952
-7,056
-5% -$79.9K 0.01% 610
2023
Q3 		$1.55M Buy
138,008
+9,571
+7% +$111K 0.01% 626
2023
Q2 		$1.29M Sell
128,437
-8,284
-6% -$76.9K 0.01% 665
2023
Q1 		$1.28M Sell
136,721
-22,681
-14% -$268K 0.01% 699
2022
Q4 		$1.95M Buy
159,402
+57,832
+57% +$721K 0.01% 605
2022
Q3 		$1.26M Buy
101,570
+790
+0.8% +$13.8K 0.01% 632
2022
Q2 		$1.98M Buy
100,780
+11,949
+13% +$283K 0.01% 546
2022
Q1 		$2.32M Sell
88,831
-18,477
-17% -$492K 0.01% 558
2021
Q4 		$3.04M Sell
107,308
-30,586
-22% -$951K 0.01% 537
2021
Q3 		$4.4M Sell
137,894
-129,146
-48% -$4.33M 0.02% 495
2021
Q2 		$9.26M Buy
267,040
+46,962
+21% +$1.55M 0.02% 483
2021
Q1 		$6.48M Buy
220,078
+8,646
+4% +$266K 0.01% 557
2020
Q4 		$35.7M Buy
211,432
+10,580
+5% +$323K 0.02% 545
2020
Q3 		$5.61M Sell
200,852
-43,216
-18% -$1.1M 0.02% 527
2020
Q2 		$5.23M Buy
244,068
+183,200
+301% +$4.05M 0.02% 508
2020
Q1 		$1.36M Buy
60,868
+1,320
+2% +$36.2K 0.01% 634
2019
Q4 		$1.75M Sell
59,548
-190,173
-76% -$5.17M 0.01% 717
2019
Q3 		$6.64M Sell
249,721
-16,124
-6% -$484K 0.05% 392
2019
Q2 		$8.99M Buy
265,845
+28,320
+12% +$919K 0.07% 324
2019
Q1 		$7.62M Buy
+237,525
New +$7.31M 0.06% 345

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

KBC Group's ELAN Position: Q1 2026 in Review

KBC Group increased its Elanco Animal Health (ELAN) stake by 1.8% in Q1 2026, buying an estimated $40.1K and bringing the position to 91,785 shares worth $2.2M. The position accounts for 0.01% of the portfolio, ranked #642.

KBC Group first reported a position in ELAN in Q1 2019 and has held it in 29 quarters since. The position peaked at $35.7M in Q4 2020. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • KBC Group held 91,785 shares of Elanco Animal Health worth $2.2M as of Q1 2026.
  • KBC Group bought 1,639 Elanco Animal Health shares in Q1 2026, an estimated $40.1K.
  • Elanco Animal Health made up 0.01% of KBC Group's portfolio in Q1 2026, its #642 holding.
  • KBC Group first reported a position in Elanco Animal Health in Q1 2019 and has held it in 29 quarters since.
  • KBC Group's Elanco Animal Health position peaked at $35.7M in Q4 2020.
  • 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.